CRISPR-on-a-Chip For Diagnosing Cancer May Soon Be a Thing – Singularity Hub
Singularity Hub |
CRISPR-on-a-Chip For Diagnosing Cancer May Soon Be a Thing
Singularity Hub More recently, Cpf1 was used in the DETECTR system to snag cancer-causing viruses. The protein has a seemingly bright future: the gene-editing company Editas licensed it for further development in 2016. The swap did the trick. To help the CRISPR system … Top Gene-Editing Stocks for Long-Term Investors — The Motley Fool |
